JBC Oz Biosciences

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M111686200 on March 1, 2002

J. Biol. Chem., Vol. 277, Issue 19, 16712-16717, May 10, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/19/16712    most recent
M111686200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Collinson, E. J.
Right arrow Articles by Grant, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Collinson, E. J.
Right arrow Articles by Grant, C. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Yeast Glutaredoxins Are Active as Glutathione Peroxidases*

Emma J. CollinsonDagger §, Glen L. WheelerDagger , Ester Ocón GarridoDagger , Angela M. Avery, Simon V. Avery, and Chris M. GrantDagger ||

From the Dagger  Department of Biomolecular Sciences, University of Manchester Institute of Science and Technology, Manchester M60 1QD, United Kingdom and the  School of Life and Environmental Sciences, University of Nottingham, University Park, Nottingham NG7 2RD, United Kingdom

Received for publication, December 7, 2001, and in revised form, February 25, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The yeast Saccharomyces cerevisiae contains two glutaredoxins, encoded by GRX1 and GRX2, which are active as glutathione-dependent oxidoreductases. Our studies show that changes in the levels of glutaredoxins affect the resistance of yeast cells to oxidative stress induced by hydroperoxides. Elevating the gene dosage of GRX1 or GRX2 increases resistance to hydroperoxides including hydrogen peroxide, tert-butyl hydroperoxide and cumene hydroperoxide. The glutaredoxin-mediated resistance to hydroperoxides is dependent on the presence of an intact glutathione system, but does not require the activity of phospholipid hydroperoxide glutathione peroxidases (GPX1-3). Rather, the mechanism appears to be mediated via glutathione conjugation and removal from the cell because it is absent in strains lacking glutathione-S-transferases (GTT1, GTT2) or the GS-X pump (YCF1). We show that the yeast glutaredoxins can directly reduce hydroperoxides in a catalytic manner, using reducing power provided by NADPH, GSH, and glutathione reductase. With cumene hydroperoxide, high pressure liquid chromatography analysis confirmed the formation of the corresponding cumyl alcohol. We propose a model in which the glutathione peroxidase activity of glutaredoxins converts hydroperoxides to their corresponding alcohols; these can then be conjugated to GSH by glutathione-S-transferases and transported into the vacuole by Ycf1.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

All aerobic organisms are exposed to reactive oxygen species (ROS),1 such as H2O2, the superoxide anion, and the hydroxyl radical during the course of normal aerobic metabolism or following exposure to radical-generating compounds. These ROS can cause wide-ranging damage to cells, and an oxidative stress is said to occur when the cellular survival mechanisms are unable to cope with the ROS or the damage they cause (1). Oxidative damage is associated with various diseases such as cancer, vascular, and neurodegenerative disorders, as well as with aging processes (2-4). To protect against damage, cells contain a number of defense mechanisms including enzymes, such as catalase, superoxide dismutase, glutathione peroxidase, and low molecular weight antioxidants such as glutathione (GSH) and vitamins C and E (5, 6). Recent studies have highlighted the key role played by sulfhydryl groups (-SH) in the response to oxidative stress, and in particular, the roles of the GSH/glutaredoxin and thioredoxin systems, which maintain the redox homeostasis of the cell (7-10). In this present study, we examine the role of yeast glutaredoxins in protection against hydroperoxides.

Glutaredoxins are small heat-stable oxidoreductases, first discovered in Escherichia coli as GSH-dependent hydrogen donors for ribonucleotide reductase (11). They form part of the glutaredoxin system, comprising NADPH, GSH, and glutathione reductase, which transfers electrons from NADPH to glutaredoxins via GSH (12). The yeast Saccharomyces cerevisiae contains two glutaredoxins, designated Grx1 and Grx2, which share 40-52% identity and 61-76% similarity with those from bacterial and mammalian species (13). In common with all classical glutaredoxins, the active sites of Grx1 and Grx2 contain two highly conserved redox-active cysteine residues. Strains deleted for both GRX1 and GRX2 are viable, but lack heat-stable oxidoreductase activity in experiments using beta -hydroxyethylene disulfide as a model disulfide substrate. A new family of glutaredoxin-related proteins has been identified in yeast (GRX3-5) that is conserved throughout evolution from bacterial to mammalian species (14). These glutaredoxin-like proteins differ from classical glutaredoxins in that they contain a single cysteine residue at their putative active sites. Thus, they would be unlikely to substitute for glutaredoxins or thioredoxins as oxidoreductases with substrates like ribonucleotide reductase, which require a dithiol mechanism (15). The triple mutant lacking all three isoforms (grx3-5) is inviable, and interestingly, a grx2 grx5 mutant is also inviable indicating that there may be some overlapping function between the two classes of glutaredoxins.

Previous studies have shown that the yeast glutaredoxins are active as antioxidants and are required for protection against ROS. Mutants lacking the dithiol glutaredoxins are sensitive to oxidative stress conditions, and the grx1 mutant is hypersensitive to the superoxide anion (13). In contrast, both grx1 and grx2 mutants are sensitive to H2O2, with the grx2 mutant showing slightly higher sensitivity compared with the grx1 mutant. In addition, overexpression of GRX1 or GRX2 increased resistance to H2O2. Furthermore, the expression of GRX1 and GRX2 is up-regulated in response to various stress conditions, including exposure to oxidants, with both genes regulated by stress-responsive elements (STRE) (16). In this present study, we investigated the antioxidant activity of the yeast glutaredoxins against hydroperoxides and show that they have glutathione peroxidase activity. This is the first evidence that glutaredoxins can protect against the damaging effects of ROS by directly reducing hydroperoxides.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Yeast Strains and Growth Conditions-- The S. cerevisiae strains used in this study are described in Table I. Strains were grown in rich YEPD medium (2% w/v glucose, 2% w/v bactopeptone, 1% w/v yeast extract) or minimal synthetic-defined media (0.17% w/v yeast nitrogen base without amino acids, 5% w/v ammonium sulfate, 2% w/v glucose) supplemented with appropriate amino acids and bases: 2 mM leucine, 4 mM isoleucine, 1 mM valine, 0.3 mM histidine, 0.4 mM tryptophan, 1 mM lysine, 0.15 mM adenine, 0.2 mM uracil. Media were solidified by the addition of 2% (w/v) agar.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Yeast strains used in this study

Sensitivity to Oxidants-- Dose-response curves to H2O2, tert-butyl hydroperoxide (t-BH) and cumene hydroperoxide (CHP) were made by growing cells to exponential phase (A600 = 1) in synthetic-defined medium at 30 °C and treating with oxidants for 1 h. Aliquots of cells were diluted in fresh YEPD medium and plated in triplicate on YEPD plates to obtain viable counts after 3 days of growth.

Plasmids-- Multi-copy plasmids containing GRX1 and GRX2 were constructed in the 2-µ yeast high-copy vector YEp24. For GRX1, a 1264-bp fragment was cut from the polylinker region of pG501 (13) using BamHI and XhoI sites and cloned into the BamHI and SalI sites of YEp24. For GRX2, a 1464-bp fragment was cut from the polylinker region of pL4 (13) using BamHI and SalI sites and cloned into the BamHI and SalI sites of YEp24.

Protein Purification and Antibody Production-- Plasmid pBAD-YGRX1 contained a six-histidine residue-tagged version of GRX1 and was a kind gift from Barry Rosen (17). Grx1 was purified via the His tag using Ni2+ agarose columns as described previously (17). Purified fusion protein was used to generate rabbit anti-yeast glutaredoxin antibody (Biogenesis Ltd., Poole, UK). Recombinant PHGpx2 was purified as described previously (18).

Western Blot Analysis-- Protein extracts were electrophoresed under reducing conditions on 15% SDS-PAGE mini-gels and electroblotted onto polyvinylidene difluoride membrane (Amersham Biosciences). Blots were incubated in anti-Grx1 antibody (1 in 1000 dilution). Bound antibody was visualized by chemiluminescence (ECL, Amersham Biosciences) following incubation of the blot in donkey anti-rabbit immunoglobulin-horseradish peroxidase conjugate (Amersham Biosciences).

Determination of Peroxidase Activity-- The peroxidase activity of Grx1 with H2O2, t-BH, and CHP was measured in vitro with purified Grx1. The components of the reaction mixture were NADPH (0.4 mM), GSH (1 mM), Glr1 (6 µg/ml), Grx1 (5 pmol), and varying concentrations of hydroperoxides in a reaction volume of 40 µl in 0.1 mM Tris HCl, pH 7.4. Reactions were started by the addition of Grx1 and followed by the decrease in absorbance at 340 nm due to the oxidation of NADPH using a microplate reader. In this assay, oxidized glutathione (GSSG) produced by the glutaredoxin catalyzed reduction of hydroperoxides is reduced by Glr1. Reactions are followed by the oxidation of NADPH, which is coupled to the reduction of GSSG to GSH by Glr1. PHGpx2 was assayed for glutathione peroxidase activity using 5 pmol of recombinant protein exactly as described for Grx1.

HPLC Analysis of Cumene Hydroperoxide and Cumyl Alcohol-- The Reduction of CHP to cumyl alcohol by Grx1 was detected by HPLC analysis using a method described previously (19). The reaction was performed in 50 mM potassium phosphate buffer, pH 7.0, with 0.4 mM NADPH, 1 mM GSH, 6 µg/ml Glr1, Grx1 (5 pmol), and 0.25 mM CHP in a reaction volume of 500 µl. Control reactions were run in parallel either omitting Grx1 or GSH. The reaction mixtures were incubated at room temperature for 1 h and terminated by the addition of 500 µl of HPLC-grade ethyl acetate and 0.2 g of NaCl, followed by vortex mixing and centrifugation. The upper phase containing ethyl acetate, cumene hydroperoxide, and cumyl alcohol was removed and stored on ice prior to analysis. Reaction mixtures were separated using a Dionex SummitTM HPLC system with a Spherisorb octadecyl silane (2) 5 µ of HPLC steel column (4.5 × 250 mM). Isocratic elution was performed using 35% acetonitrile in 5 mM KH2PO4, pH 7.0, at a flow rate of 1.5 ml/min. The separation was followed at 254 nm.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Glutaredoxins Are Required for Resistance to Hydroperoxides-- To further investigate the role of glutaredoxins in protection against oxidative stress, we examined the ability of glutaredoxin overexpression to increase resistance to hydroperoxides (Fig. 1). Overexpression of GRX1 and GRX2 was achieved using multi-copy plasmids and was confirmed by means of Western blot analysis (Fig. 1D). Resistance to H2O2 (Fig. 1A), tert-butyl hydroperoxide (t-BH, Fig. 1B) and cumene hydroperoxide (CHP, Fig. 1C) was determined using dose-response curves following a 1 h exposure. Elevating the levels of Grx1 or Grx2 was found to increase the resistance of a wild-type strain to H2O2, and CHP compared with the vector alone control. Interestingly, overexpression of GRX1 increased resistance to t-BH, whereas, overexpression of GRX2 had little or no effect. Thus, changes in the levels of glutaredoxins were found to affect the resistance of yeast cells to oxidative stress induced by hydroperoxides. To determine the mechanism of this glutaredoxin-mediated hydroperoxide resistance, we next examined its dependence on the components of the glutathione system.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 1.   Overexpression of glutaredoxins increases resistance to hydroperoxides. The wild-type strain containing YEp24, mcGRX1, or mcGRX2 was tested for oxidant sensitivity by growing strains to exponential phase in synthetic-defined medium and treating with 4 mM H2O2 (A), 15 mM t-BH (B), or 2 mM CHP (C). Cells were diluted and plated in triplicate on to YEPD medium to monitor cell viability after 60 min of exposure. Percentage survival is expressed relative to the untreated controls. Overexpression of GRX1 and GRX2 was confirmed by means of Western blot analysis using an anti-glutaredoxin antibody (D).

Glutaredoxin-mediated Protection against Hydroperoxides Is Dependent on Glutathione but Not Mediated by Glutathione Peroxidases-- The effect of overexpressing GRX1 and GRX2 on resistance to hydroperoxides was examined in strains deleted for GSH1 or GLR1. GSH1 encodes gamma -glutamylcysteine synthetase, the first enzyme in the GSH biosynthetic pathway (20), and GLR1 encodes glutathione reductase, which recycles oxidized glutathione (GSSG) to its reduced form (GSH) (21). The gsh1 and glr1 mutants were sensitive to CHP compared with the wild-type strain, with the strain lacking GLR1 showing highest sensitivity (Fig. 2). Glutaredoxin-mediated resistance to hydroperoxides was dependent on the glutathione system because neither of the glutathione mutants with mcGRX1 or mcGRX2 showed increased resistance to CHP.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 2.   Glutaredoxin-mediated protection against hydroperoxides is dependent on glutathione but is not mediated by glutathione peroxidases. Wild-type cells (CY4) and gsh1, glr1, and gpx1-3 mutants were transformed with YEp24, mcGRX1, or mcGRX2 and tested for sensitivity to 2 mM CHP as described for Fig. 1A.

One key antioxidant function of GSH is as a cofactor for glutathione peroxidases. Yeast contains three phospholipid hydroperoxide glutathione peroxidases (GPX1-3), which are required for resistance to oxidative stress induced by H2O2 and t-BH (18, 22). We, therefore, tested whether these enzymes are required for the glutaredoxin-mediated resistance to hydroperoxides using a gpx1-3 triple mutant (Fig. 2). The strain deleted for GPX1-3 did not show increased sensitivity to CHP compared with the wild-type strain. In addition, mcGRX1 and mcGRX2 led to a 1.7-fold increase in resistance to CHP. This was slightly reduced compared with the wild-type strain (2-fold increase in resistance), but these data indicate that glutathione peroxidases are not essential for the glutaredoxin-mediated resistance to hydroperoxides. We next examined the requirement for other GSH-dependent enzymes in protection against hydroperoxides.

Glutaredoxin-mediated Protection against Hydroperoxides Is Dependent on Gtt1, Gtt2, and Ycf1-- Glutathione-S-transferases from mammalian systems can act as general hydroperoxidases catalyzing the breakdown of alkyl hydroperoxides to their corresponding alcohols (23). Two genes encoding functional glutathione-S-transferases, designated GTT1 and GTT2, have been identified in yeast (24). These enzymes form part of a xenobiotic detoxification pathway that catalyzes the formation of glutathione conjugates, which are removed to the vacuole via an ATP-dependent GS-X pump, encoded by YCF1 (25). The role of this system in hydroperoxide protection was tested by overexpressing GRX1 and GRX2 in strains deleted for GTT1, GTT2, or YCF1 (Fig. 3). Loss of GTT1 or GTT2 did not affect the basal level of resistance to CHP. However, the increased resistance to CHP mediated by GRX1 and GRX2 was completely abrogated in the gtt1 and gtt2 mutants. The ycf1 mutant was slightly more sensitive to CHP compared with the wild-type strain. Interestingly, overexpression of GRX1 or GRX2 in the ycf1 mutant resulted in increased sensitivity to CHP compared with the vector alone control. This indicates that glutaredoxins may convert CHP to a product that is toxic in the absence of YCF1 (see "Discussion"). Overexpression of GRX1 and GRX2 in the gtt1, gtt2, and ycf1 mutants was confirmed by Western blot analysis (data not shown). The requirement for GTT1, GTT2, and YCF1 indicates that glutaredoxin-mediated detoxification may involve the conjugation of hydroperoxides to GSH prior to their removal from the cell. However, given that Gtt1 does not contain a cysteine residue (24), it is unlikely that oxidoreductases such as Grx1 or Grx2 can directly affect the activity of the glutathione-S-transferases. We therefore tested whether the yeast glutaredoxins could directly reduce hydroperoxides prior to their removal by the GSH conjugation system.


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 3.   Glutaredoxin-mediated protection against hydroperoxides is dependent on Gtt1, Gtt2, and Ycf1. Wild-type cells (BY4742) and gtt1, gtt2, and ycf1 mutants were transformed with YEp24, mcGRX1, or mcGRX2 and tested for sensitivity to 2 mM CHP as described for Fig. 1A.

Glutaredoxins Have Glutathione Peroxidase Activity-- The ability of glutaredoxins to reduce hydroperoxides was tested in vitro using purified Grx1. Reaction mixtures contained GSH, Glr1, NADPH, and CHP (0.25 mM) and were started by the addition of Grx1 (Fig. 4A). Reactions were followed by the oxidation of NADPH, which is coupled to the reduction of GSSG to GSH by Glr1. In the presence of all components of the assay, oxidation of NADPH was observed indicating that Grx1 can reduce CHP (Fig. 4A). The reaction is dependent on the presence GSH, Glr1, NADPH, and Grx1 because there was little or no activity when each was omitted from the assay (Fig. 4A). The reduction of CHP was analyzed using differing amounts of Grx1 (Fig. 4B) and was found to show strict linearity confirming that Grx1 has efficient catalytic activity as a peroxidase.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 4.   Reduction of CHP catalyzed by Grx1. A, the peroxidase activity of Grx1 with CHP was measured in vitro with purified Grx1. The components of the complete reaction mixture were NADPH (0.4 mM), GSH (1 mM), Glr1 (6 µg/ml), and CHP (0.25 mM) in 0.1 mM Tris-HCl, pH 7.4. Reactions were started by the addition of 5 pmol of Grx1 and followed by the decrease in A340 attributable to the oxidation of NADPH. Peroxidase activity was dependent on the presence of GSH, Glr1, and NADPH because minimal activity was detected in reactions where each component was omitted individually. B, the reduction of CHP was found to show strict linearity with Grx1 at concentrations ranging from 5-25 pmol.

The ability of Grx1 to act as a general hydroperoxidase was investigated using varying concentrations of H2O2, t-BH, and CHP (Fig. 5A). Grx1 could reduce all three hydroperoxides, and peroxidase activity was hyperbolic with respect to the concentration of peroxide used. Grx1 showed the greatest activity with H2O2 (Vmax = 110.2 µmol/min/mg), compared with t-BH (Vmax = 7.5 µmol/min/mg) and CHP (Vmax = 32.5 µmol/min/mg). To address the question of whether Grx1 is a good peroxidase enzyme, the activity of Grx1 was compared with the yeast PHGpx2 enzyme (Fig. 5B). PHGpx2 was also able to reduce all three hydroperoxides and, similarly, showed the greatest activity with H2O2. The in vitro peroxidase activity of Grx1 is comparable with that of the PHGpx2 glutathione peroxidase enzyme.


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 5.   Peroxidase activity of Grx1 and PHGpx2 with different hydroperoxide substrates. The peroxidase activity of Grx1 (A) and PHGpx2 (B) was tested with various concentrations of H2O2, t-BH, and CHP using the complete reaction mix described for Fig. 4 above. 5 pmol of recombinant Grx1 or PHGpx2 was used in each reaction. The Km and Vmax values for each hydroperoxide substrate were calculated using Eadie Ofstee plots (not shown).

Following the observation that Grx1 could reduce hydroperoxides, we used HPLC analysis to directly follow the conversion of CHP to the reduced product, cumyl alcohol (Fig. 6). The commercial CHP used in these studies was resolved as two peaks when chromatographed and contained a low level of cumyl alcohol. Incubation of 0.25 mM CHP with 5 pmol of Grx1 for 1 h resulted in an increase in the peak corresponding to cumyl alcohol, confirming that Grx1 could reduce CHP to cumyl alcohol. The reaction was shown to be Grx1- and GSH-dependent because there was no accumulation of cumyl alcohol in their absence (Fig. 6, B and C).


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 6.   Reduction of CHP to cumyl alcohol catalyzed by Grx1. Reactions were performed in 50 mM potassium phosphate buffer, pH 7.0, with 0.4 mM NADPH, 1 mM GSH, 6 µg/ml Glr1, 5 pmol of Grx1 and 0.25 mM CHP in a reaction volume of 500 µl. Reaction mixtures were separated using HPLC and followed at 254 nm. A, complete. B, without Grx1. C, without GSH.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Oxidative damage poses a very great risk to the survival of cells because it can undermine cellular structures including DNA, proteins, and lipids (26-29). In this present study, we have extended our original observation that glutaredoxins are required for protection against oxidative stress (13). In particular, glutaredoxins were found to play an important role in protecting cells against the damaging effects of hydroperoxides including H2O2, t-BH, and CHP. In addition, Grx1 and Grx2 may have some different functions, at least for the case of t-BH, since overexpression of GRX1 increased resistance to t-BH, whereas overexpression of GRX2 had no effect. Similarly, a strain lacking GRX1 is more sensitive to t-BH than a strain lacking GRX2 (data not shown) indicating that Grx1 may be more important than Grx2 for protection against this oxidant. Previous work has also indicated that the two glutaredoxin isoforms in yeast may play distinct roles. Differential gene expression of GRX1 and GRX2 in response to stress conditions was taken as evidence that the glutaredoxins are required during different growth and stress conditions, which may account for their apparent redundancy (16).

Glutaredoxins from higher eukaryotes have been shown to act as antioxidants both in the regulation of other antioxidant enzymes and in a more general way as oxidoreductases. For example, in vitro studies have shown that both the glutaredoxin and thioredoxin systems can serve as electron donors for human plasma (selenium-dependent) glutathione peroxidase (30). The yeast S. cerevisiae uniquely expresses three phospholipid hydroperoxide glutathione peroxidases and does not appear to posses any glutathione peroxidases (18). Although PHGpx1-3 are involved in the detoxification of hydroperoxides (18, 22), they were not required for the glutaredoxin-mediated antioxidant function. Ascorbic acid is another key antioxidant, which can detoxify hydrogen peroxide and other forms of ROS. Mammalian glutaredoxins can catalyze the GSH-dependent regeneration of ascorbic acid from its oxidized dehydroascorbate form (31-33). However, it is unknown whether the yeast glutaredoxins can function in a similar manner, and only the five-carbon analogue, erythroascorbic acid, has been detected in yeast (34, 35).

Mammalian glutaredoxins have also been shown to catalyze the cleavage of mixed disulfides in vitro, which may serve to protect cells by reducing any mixed disulfides formed during exposure to oxidative stress conditions (36). In addition, a correlation between protein-SSG reduction and glutaredoxin activity has been demonstrated in mammalian cells (37), and the reversible S-glutathiolation of HIV-1 protease can be catalyzed by a glutaredoxin in vitro (38). Similarly, the yeast glutaredoxins Grx1 and Grx2 can reduce the model disulfide substrate, beta -hydroxyethylene disulfide in vitro. However, they do not affect the levels of protein-GSH mixed disulfides formed in vivo in response to H2O2 (13), and recent studies have shown that the yeast thioredoxins regulate the levels of mixed disulfide formation (39).

Glutathione-S-transferases protect cells against the toxic effects of various xenobiotics. In higher eukaryotes, glutathione-S-transferases are known to detoxify lipid hydroperoxides to their corresponding alcohols and water (23). In addition, rat hepatic glutathione-S-transferase has been shown to catalyze the metabolism of ethanol to fatty acid ethyl esters (40). Two genes encoding functional glutathione-S-transferases, designated GTT1 and GTT2, have been identified in yeast (24). Purified recombinant Gtt1 and Gtt2 are active in a glutathione-S-transferase assay using CDNB as a model substrate, but share limited sequence homology with each other (11% identity, 32% similarity) and with glutathione-S-transferases from other species. Both GTT1 and GTT2 were essential for the glutaredoxin-mediated resistance to CHP. This may indicate that glutaredoxins confer resistance to hydroperoxides in a pathway that acts through GSH conjugation and removal from the cell. In agreement with this idea, increased resistance also required the GS-X pump encoded by YCF1. Ycf1 is a member of the ATP-binding cassette (ABC) protein super-family that shares extensive homology with the human multidrug resistance-associated protein (MRP1) and the cystic fibrosis transmembrane conductance regulator (hCFTR). It is also a functional homologue of MRP1 and is active in the uptake of glutathione-S-conjugates into the vacuole (25, 41). Interestingly, overexpression of GRX1 and GRX2 made the ycf1 mutant more sensitive to CHP indicating that Ycf1 may constitute the end step of a hydroperoxide detoxification pathway.

The detoxification of xenobiotics by glutathione-S-transferases is a three-stage process (24). In stage 1, the xenobiotic is activated by oxidation, reduction, or hydrolysis to introduce a functional group; in stage 2, the functional group is conjugated to GSH; and in stage 3, the GSH conjugates are eliminated from the cytosol by means of a GS-X pump. Thus, glutaredoxins may either act on hydroperoxides directly (stage 1) or, alternatively, stimulate the activity of Gtt1 and Gtt2 (stage 2). Either one of those models would end in the elimination of a GSH-conjugated xenobiotic by the Ycf1 GS-X pump. The second model was unlikely given that Gtt1 does not contain any cysteine residues and that Gtt1 and Gtt2 are active in a glutathione-S-transferase assay in the absence of glutaredoxins (24). Accordingly, we tested the ability of glutaredoxins to directly reduce hydroperoxides in a reaction coupled with NADPH, Glr1, and GSH. Grx1 was found to reduce all three hydroperoxides in a catalytic manner and, for the case of CHP, was shown to reduce it to the corresponding alcohol (cumyl alcohol). The peroxidase activity of Grx1 with t-BH was comparable with that of a yeast phospholipid hydroperoxide glutathione peroxidase (PHGPx2). In addition, the peroxidase activity of Grx1 is comparable with various eukaryotic glutathione peroxidases, which have specific activities ranging between 3.2-625 µmol/min/mg using t-BH as a substrate (reviewed in Ref. 42). Thus, one antioxidant activity of glutaredoxins appears to be the direct reduction of hydroperoxides to their corresponding alcohols.

The finding that glutaredoxins have peroxidase activity is unexpected and adds to the growing list of antioxidants that can detoxify hydroperoxides. In yeast, these include catalases (CTT1, CTA1), phospholipid hydroperoxide glutathione peroxidases (GPX1-3), and thiol peroxidases (five isoenzymes) (reviewed in Refs. 6, 43). Interestingly, a glutaredoxin/peroxiredoxin homologue has recently been identified in Chromatium gracile, which has similarity to both the glutaredoxin and peroxiredoxin families of antioxidants (44). This enzyme can reduce hydroperoxides including H2O2 and alkyl hydroperoxides using reducing power from the glutathione derivative, glutathione amide. Thus, the hydroperoxidase activity of the yeast glutaredoxins, identified in this present study, may represent an evolutionarily conserved activity. It remains to be established whether the glutaredoxins derived from higher eukaryotes similarly posses glutathione-dependent peroxidase activity.

    ACKNOWLEDGEMENTS

We are grateful to Barry Rosen for donating plasmid pBAD-YGRX1 and Lisa Israel for the gpx1-3 mutant. We thank Kathryn Quinn for helpful discussions and critical reading of the manuscript.

    FOOTNOTES

* This work was supported by the Welcome Trust Grant 060786 (to G. W.), Biotechnology and Biological Sciences Research Council Grant 36/G13234 (to E. O. G.), and the National Institutes of Health Grant R01 GM57945 (to S. A.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Holds Biotechnology and Biological Sciences Research Council Research Studentship 00/A1/P/06334.

|| To whom correspondence should be addressed: Dept. of Biomolecular Sciences, University of Manchester Institute of Science and Technology, P. O. Box 88, Manchester M60 1QD, United Kingdom. Tel.: 0161-200-4192; Fax: 0161-236-0409; Email: chris.grant@umist.ac.uk.

Published, JBC Papers in Press, March 1, 2002, DOI 10.1074/jbc.M111686200

    ABBREVIATIONS

The abbreviations used are: ROS, reactive oxygen species; YEPD, yeast extract peptone dextrose; t-BH, tert-butyl hydroperoxide; CHP, cumene hydroperoxide; HPLC, high pressure liquid chromatography.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Halliwell, B. (1991) Am. J. Med. 91, 14S-38S[Medline] [Order article via Infotrieve]
2. Lefer, D., and Granger, D. (2000) Am. J. Med. 109, 315-323[CrossRef][Medline] [Order article via Infotrieve]
3. Schulz, J., Lindenau, J., Seyfriend, J., and Dichgans, J. (2000) Eur. J. Biochem. 267, 4904-4911[Medline] [Order article via Infotrieve]
4. Wiseman, H., and Halliwell, B. (1996) Biochem. J. 313, 17-29[Medline] [Order article via Infotrieve]
5. Yu, B. P. (1994) Physiol. Rev. 74, 139-162[Free Full Text]
6. Jamieson, D. J. (1998) Yeast 14, 1511-1527[CrossRef][Medline] [Order article via Infotrieve]
7. Demple, B. (1998) Science 279, 1655-1656[Free Full Text]
8. Rietsch, A., and Beckwith, J. (1998) Ann. Rev. Genet. 32, 163-184[CrossRef][Medline] [Order article via Infotrieve]
9. Stewart, E. J., Aslund, F., and Beckwith, J. (1998) EMBO J. 17, 5543-5550[CrossRef][Medline] [Order article via Infotrieve]
10. Carmel-Harel, O., and Storz, G. (2000) Ann. Rev. Microbiol. 54, 439-461[CrossRef][Medline] [Order article via Infotrieve]
11. Holmgren, A. (1976) Proc. Natl. Acad. Sci. U. S. A. 73, 2275-2279[Abstract/Free Full Text]
12. Holmgren, A. (1990) in Glutathione: Metabolism and Physiological Functions (Vina, J., ed) , pp. 146-154, CRC Press Inc., Boca Raton, FL
13. Luikenhuis, S., Dawes, I. W., and Grant, C. M. (1998) Mol. Biol. Cell 9, 1081-1091[Abstract/Free Full Text]
14. Rodriguez-Manzaneque, M. T., Ros, J., Cabiscol, E., Sorribas, A., and Herrero, E. (1999) Mol. Cell. Biol. 19, 8180-8190[Abstract/Free Full Text]
15. Bushweller, J. H., Aslund, F., Wuthrich, K., and Holmgren, A. (1992) Biochemistry 31, 9288-9293[CrossRef][Medline] [Order article via Infotrieve]
16. Grant, C. M., Luikenhuis, S., Beckhouse, A., Soderbergh, M., and Dawes, I. W. (2000) Biochim. Biophys. Acta 1490, 33-42[Medline] [Order article via Infotrieve]
17. Mukhopadhyay, R., Shi, J., and Rosen, B. P. (2000) J. Biol. Chem. 275, 21149-21157[Abstract/Free Full Text]
18. Avery, A. M., and Avery, S. V. (2001) J. Biol. Chem. 276, 33730-33735[Abstract/Free Full Text]
19. Jacobson, F. S., Morgan, R. W., Christman, M. F., and Ames, B. N. (1989) J. Biol. Chem. 264, 1488-1496[Abstract/Free Full Text]
20. Grant, C. M., MacIver, F. H., and Dawes, I. W. (1996) Curr. Genet. 29, 511-515[Medline] [Order article via Infotrieve]
21. Grant, C. M., Collinson, L. P., Roe, J.-H., and Dawes, I. W. (1996) Molec. Microbiol. 21, 171-179[CrossRef][Medline] [Order article via Infotrieve]
22. Inoue, Y., Matsuda, T., Sugiyama, K.-I., Izawa, S., and Kimura, A. (1999) J. Biol. Chem. 274, 27002-27009[Abstract/Free Full Text]
23. Zhao, T., Singhal, S., Piper, J., Cheng, J., Pandya, U., Clark-Wronski, J., Awasthi, S., and Awasthi, Y. (1999) Arch. Biochem. Biophys. 367, 216-224[CrossRef][Medline] [Order article via Infotrieve]
24. Choi, J. H., Lou, W., and Vancura, A. (1998) J. Biol. Chem. 273, 29915-29922[Abstract/Free Full Text]
25. Szczypka, M. S., Wemmie, J. A., Moye-Rowley, W. S., and Thiele, D. J. (1994) J. Biol. Chem. 269, 22853-22857[Abstract/Free Full Text]
26. Frankenberg, D., Frankenberg-Schwanger, M., and Harbich, R. (1993) Int. J. Radiat. Biol. 64, 511-521[Medline] [Order article via Infotrieve]
27. Levine, R., Williams, J., Stadtman, E., and Shacter, E. (1994) Methods Enzymol. 233, 346-357[Medline] [Order article via Infotrieve]
28. Morados-Ferreira, P., Costa, V., Piper, P., and Mager, W. (1996) Molec. Microbiol. 19, 651-658[CrossRef][Medline] [Order article via Infotrieve]
29. Steels, E. L., Learmonth, R. P., and Watson, K. (1994) Microbiology 140, 569-576[Abstract]
30. Bjornstedt, M., Xue, J., Huang, W., Akesson, B., and Holmgren, A. (1994) J. Biol. Chem. 269, 29382-29384[Abstract/Free Full Text]
31. Wells, W. W., Xu, D. P., Yang, Y., and Rocque, P. A. (1990) J. Biol. Chem. 265, 15361-15364[Abstract/Free Full Text]
32. Park, J. B., and Levine, M. (1996) Biochem. J. 315, 931-938[Medline] [Order article via Infotrieve]
33. Meister, A. (1994) J. Biol. Chem. 269, 9397-9400[Free Full Text]
34. Kim, H. S., Seib, P. A., and Chung, O. K. (1993) J. Food. Sci. 58, 845-862[CrossRef]
35. Nick, J. A., Leung, C. T., and Loewus, F. A. (1986) Plant. Sci. 46, 181-187
36. Chrestensen, C. A., Eckman, C. B., Starke, D. W., and Mieyal, J. J. (1995) FEBS Lett. 374, 25-28[CrossRef][Medline] [Order article via Infotrieve]
37. Chrestensen, C. A., Starke, D. W., and Mieyal, J. J. (2000) J. Biol. Chem. 275, 26556-26565[Abstract/Free Full Text]
38. Davis, D. A., Newcomb, F. M., Starke, D. W., Ott, D. E., Mieyal, J. J., and Yarchoan, R. (1997) J. Biol. Chem. 272, 25935-25940[Abstract/Free Full Text]
39. Ocón Garrido, E., and Grant, C. M. (2001) Molecular Microbiol. 43, 993-1003
40. Bora, P. S., Spilburg, C. A., and Lange, L. G. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 4470-4473U[Abstract/Free Full Text]. S. A. 86, 4470-4473
41. Ze-Sheng, L., Szczypka, M., Lu, Y.-P., Thiele, D. J., and Rea, P. A. (1996) J. Biol. Chem. 271, 5609-6517
42. Tran, L.-T., Inoue, Y., and Kimura, A. (1993) Biochim. Biophys. Acta 1164, 166-172[CrossRef][Medline] [Order article via Infotrieve]
43. Grant, C. M. (2001) Mol. Microbiol. 39, 533-541[CrossRef][Medline] [Order article via Infotrieve]
44. Vergauwen, B., Pauwels, F., Jacquemotte, F., Meyer, T., Cusanovich, M., Bartsch, R., and Van Beeumen, J. (2001) J. Biol. Chem. 276, 20890-20897[Abstract/Free Full Text]
45. Lee, J.-C., Straffon, M. J., Jang, T.-Y., Grant, C. M., and Dawes, I. W. (2001) FEMS Yeast Research 1, 57-65[Medline] [Order article via Infotrieve]
46. Grant, C. M., MacIver, F. M., and Dawes, I. W. (1996) Mol. Microbiol. 22, 739-746[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
F. Auchere, R. Santos, S. Planamente, E. Lesuisse, and J.-M. Camadro
Glutathione-dependent redox status of frataxin-deficient cells in a yeast model of Friedreich's ataxia
Hum. Mol. Genet., September 15, 2008; 17(18): 2790 - 2802.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
L. Barreto, A. Garcera, K. Jansson, P. Sunnerhagen, and E. Herrero
A Peroxisomal Glutathione Transferase of Saccharomyces cerevisiae Is Functionally Related to Sulfur Amino Acid Metabolism
Eukaryot. Cell, October 1, 2006; 5(10): 1748 - 1759.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Tanaka, S. Izawa, and Y. Inoue
GPX2, Encoding a Phospholipid Hydroperoxide Glutathione Peroxidase Homologue, Codes for an Atypical 2-Cys Peroxiredoxin in Saccharomyces cerevisiae
J. Biol. Chem., December 23, 2005; 280(51): 42078 - 42087.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
L. Walsh, P.W. Hastwell, P.O. Keenan, A.W. Knight, N. Billinton, and R.M. Walmsley
Genetic modification and variations in solvent increase the sensitivity of the yeast RAD54-GFP genotoxicity assay
Mutagenesis, September 1, 2005; 20(5): 317 - 327.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
T. A. Missall, J. F. Cherry-Harris, and J. K. Lodge
Two glutathione peroxidases in the fungal pathogen Cryptococcus neoformans are expressed in the presence of specific substrates
Microbiology, August 1, 2005; 151(8): 2573 - 2581.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
E. W. Trotter and C. M. Grant
Overlapping Roles of the Cytoplasmic and Mitochondrial Redox Regulatory Systems in the Yeast Saccharomyces cerevisiae
Eukaryot. Cell, February 1, 2005; 4(2): 392 - 400.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. Avery, S. A. Willetts, and S. V. Avery
Genetic Dissection of the Phospholipid Hydroperoxidase Activity of Yeast Gpx3 Reveals Its Functional Importance
J. Biol. Chem., November 5, 2004; 279(45): 46652 - 46658.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. G. Kilili, N. Atanassova, A. Vardanyan, N. Clatot, K. Al-Sabarna, P. N. Kanellopoulos, A. M. Makris, and S. C. Kampranis
Differential Roles of Tau Class Glutathione S-Transferases in Oxidative Stress
J. Biol. Chem., June 4, 2004; 279(23): 24540 - 24551.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
P.A. Cahill, A.W. Knight, N. Billinton, M.G. Barker, L. Walsh, P.O. Keenan, C.V. Williams, D.J. Tweats, and R.M. Walmsley
The GreenScreen(R) genotoxicity assay: a screening validation programme
Mutagenesis, March 1, 2004; 19(2): 105 - 119.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Orlandi, M. Bettiga, L. Alberghina, and M. Vai
Transcriptional Profiling of ubp10 Null Mutant Reveals Altered Subtelomeric Gene Expression and Insurgence of Oxidative Stress Response
J. Biol. Chem., February 20, 2004; 279(8): 6414 - 6425.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Murata, Y. Ihara, H. Nakamura, J. Yodoi, K. Sumikawa, and T. Kondo
Glutaredoxin Exerts an Antiapoptotic Effect by Regulating the Redox State of Akt
J. Biol. Chem., December 12, 2003; 278(50): 50226 - 50233.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Tamarit, G. Belli, E. Cabiscol, E. Herrero, and J. Ros
Biochemical Characterization of Yeast Mitochondrial Grx5 Monothiol Glutaredoxin
J. Biol. Chem., July 3, 2003; 278(28): 25745 - 25751.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. J. Collinson and C. M. Grant
Role of Yeast Glutaredoxins as Glutathione S-transferases
J. Biol. Chem., June 13, 2003; 278(25): 22492 - 22497.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/19/16712    most recent
M111686200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow